CHEK2 and cancer: A missense variant I157T affects the forkhead-associated (FHA) domain, where it mediates ATM-dependent CHEK2 phosphorylation and targeting of CHEK2 to bind partners such as BRCA1 [18] and is associated with reduced DNA repair ability and increased risk for various cancers [19].